Citations 1
Activity of oral irinotecan (IRI) in metastatic breast cancer (MBC) patients after prior anthracycline, taxane and capecitabine: Phase 2 study results
Vukelja, S., O’Shaughnessy, J., Blum, JL, Yardley, DA , Mainwaring, Paul N. , Senecal, Frank M., Benner, Rebecca, Denis, L., Pérez, E., Vukelja, Svetislava J., Campos-Gómez, Saúl , Vahdat, Linda T.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 562-562
